Data deposition footnote:
The sequences of new PENK, VGF, and NEUG peptides reported in this paper will appear in the UniProt Knowledgebase under the accession numbers P04094, P20156, and Q04940.
Introduction
In mammalian brain, the striatum plays a critical role for planning and executing voluntary movements, and is also involved in cognitive processes (1) . The striatum makes use of a complex network architecture connecting specialized anatomical structures to achieve these highly integrated tasks. It receives projections from primary sensory and motor cortices as well as motor thalamic nuclei, and sends projections to downstream basal ganglia structures, thereby influencing the control of cortical and brainstem motor systems (2) . In this context, communication within and between brain structures appears as a key element for brain functioning. For cell-to-cell communication, secreted proteins play a pivotal regulatory role. To enter the secretory pathway, it has been long assumed that an N-terminal signal peptide sequence is strictly required. However, recent studies have shown that ER-and Golgi-independent or nonclassical mechanisms may be responsible for protein secretion (3) . The extracellular medium is thus more complex than previously suspected, and its characterization has gained a special interest (4, 5) . In silico analyses suggest that mature proteins secreted via classical and non-classical mechanisms share common physicochemical properties (6) . In this respect, proteomics is a powerful approach for systematically analyzing proteins present in the extracellular medium (7-9). For neurochemical monitoring of secretome within the brain, only few tools provide an appropriate insight into its spatial and temporal dynamics. Microdialysis, in particular, has been shown to be a powerful tool for exploring the extracellular content of the brain in vivo (10) (11) (12) and for obtaining vital physiological information that cannot be gleaned from in vitro experiments. The combination of this sampling method with mass spectrometry facilitates investigation of the brain secretome in vivo. However, due to the low concentration of proteins in dialysate, which makes investigations challenging in terms of sensitivity, few studies have combined in vivo brain microdialysis and proteomic/peptidomic analysis (13) (14) (15) (16) .
In this study, to investigate both proteins and peptides secreted in rat striatum, we performed mass spectrometry analysis of microdialysis fluids. Microdialysis of small and large proteins was carried out using various cut-off probes, and the samples were analyzed through proteomic and peptidomic approaches. In addition, we used spectrum counting (17, 18) to measure the relative abundance of secreted proteins and their processed peptides, and to study the modulation of these abundances during neuronal depolarization. This approach allowed us to point out the secretion of new neuropeptides, including neurotransmitters. from three animals were pooled and digested overnight at 37°C with 10 #g of trypsin in a 25 mM ammonium bicarbonate solution. Tryptic samples were desalted and concentrated onto a C18 Ziptip (Millipore, Bedford, USA) before nLC-MS/MS analysis.
Peptide samples. For peptide analysis, we used only probes with a 20-kDa cutoff point.
For each analysis, six microdialysate collections from three animals were pooled and directly desalted and concentrated on a C18 Ziptip before nLC-MS/MS analysis.
Long-peptide investigation. This analysis was performed on samples collected in KCl condition using probes with a 20-kDa cutoff point. For each analysis, six microdialysate collections from three animals were pooled, concentrated in a Speed-Vac, and directly injected into an LTQ mass spectrometer.
Mass spectrometry analysis.
For Q-TOF and Orbitrap analysis, the dried peptide extracts were resuspended in 5% ACN and 1% trifluoroacetic acid in water and transferred into vials suitable for nano-LC-MS/MS analysis.
Q-TOF.
Analyses were performed on a nano-LC system coupled to a Q-TOF Ultima mass spectrometer (Waters, Milford, USA). During the chromatography step, peptides were concentrated on a 300 #m x 5 mm PepMap C18 precolumn (LCPackings, Sunnyvale, CA), and separated onto a C18 column (75 #m x 150 mm) (LC-Packings).
Mobile phases consisted of (A) 0.1% formic acid, 97.9% water and 2% ACN (v/v/v) and (B) 0.08% formic acid and 20% water in 79.92% ACN (v/v/v). The nanoflow rate was set to 250 nl/min and the gradient profile was as follows: from 10% to 40% B in 65 min; from 40% to 90% B in 10 min; constant 90% B for 10 min and return to 10% B. The system was calibrated every week with GFP peptide and mass shift precision was below 0.4 Da.
The mass spectrometer operated in the positive ion electrospray ionization mode with a resolution of 9000 to 11000 full-width half-maximum. Data-dependent analysis was used for MS/MS (three most abundant ions in each cycle): 1 s MS (m/z 400-1600) and maximum 5 s MS/MS (m/z 50-1850, continuum mode) with 2 min dynamic exclusion.
MS/MS raw data were processed with MassLynx 4.0 software (smooth 3/2 Savitzky Golay) (Waters).
Orbitrap. Orbitrap analyses were performed on a nano-LC system (Ultimate 3000, Dionex) coupled to an Orbitrap mass spectrometer (ThermoFischer Scientific). During the chromatography step, peptides were concentrated on a 300 #m X 5 mm PepMap C18 precolumn, and separated onto a 75 #m X 150 mm C18 column (Gemini C18 phase, Phenomenex, USA, for in-house built columns). Mobile phases consisted of (A) 0.1% formic acid, 97.9% water and 2% ACN (v/v/v) and (B) 0.08% formic acid, 20% water in 79.92% ACN (v/v/v). The nanoflow rate was set at 300 nl/min and the gradient profile was as follows: constant 4% B for 3 min; from 4% to 55% B in 42 min; from 55% to 90% B in 1 min; constant 90% B for 14 min and return to 10% B. The system was calibrated weekly with a mixture of caffeine, MRFA peptide and Ultramark (Sigma, S t Louis, USA) and mass precision was better than 5 ppm. The mass spectrometer operated in the positive ion electrospray ionization mode with a resolution of 30,000 fullwidth half-maximum. MS and MS/MS data were acquired and processed automatically with Xcalibur 2.0.7 (Thermo Fischer Scientific) and Mascot Distiller 2.1.1.0 (smooth 3/2 Savitzky Golay) (Matrix Science, Boston, USA) softwares.
LTQ.
We investigated long peptides by analyzing samples in an ion trap mass spectrometer (LTQ, Thermo Electron, Bremen, Germany). The instrument was coupled to an Ultimate 3000 (LCPackings, Sunnyvale, CA) high performance liquid chromatograph. In the chromatography step, microdialysate samples were loaded directly onto a LC-Packings monolithic pre-column (PS-DVB, 200 #m ID, 5 mm long), desalted by running mobile phase A (see below) through the column for 4 minutes and separated on a LC-Packings monolithic nano-column (PepSwift, PS-DVB, 100#m ID, 5 cm long). Mobile phases consisted of (A) 0.1% formic acid, 97.9% water and 2% ACN (v/v/v) and (B) 0.08% formic acid and 20% water in 79.92% ACN (v/v/v). The nanoflow rate was set at 300 nl/min and the gradient profile was as follows: from 0% to 50% B over 120 min; from 60% to 90% B over 10 min; constant 90% B for 10 min and return to 0% B over 1 min. Mass spectrometry data were acquired in a three-step scanning Spectrum counting. Spectrum counting (SC) was based on Orbitrap analyses with biological and analytical replicates. The spectrum counting is the total number of assigned spectra (redundant plus non-redundant) associated to a given protein. To estimate relative abundance of a given protein, a single value was calculated from individual spectrum counting summed from different analyses, and the resulting spectrum count was normalized by the protein molecular weight (MW) (17, 19) . To compare protein abundance between basal and KCl samples, spectrum counting was normalized by total spectrum counting of assigned spectra for each analysis and averaged over replicates (20, 21) . Peptides shared by multiple proteins were attributed to a single precursor, corresponding to the protein with the best Mascot score. The significance of differences between sets of conditions was assessed by Mann and Whitney test. Differences were considered significant for p values < 0.05.
Proteomic data mining.
Validated hits for each analysis were transferred to a relational database. This database made it possible to carry out specific queries concerning, for example, the number of spectra and/or unique peptides assigned to a given protein, best Mascot score and best coverage. For each protein of the database, molecular weight was retrieved from Uniprot (http://www.expasy.uniprot.org/). The SignalP (22) and SecretomeP programs (6) Shimadzu). Significant differences between conditions were tested using ANOVA and
Fisher's post-hoc PLSD test. Results were deemed significant for a p value < 0.05. Timing of microdialysis sample collection was validated by relative quantification (spectrum counting with normalization based on MW, see below) of blood-specific highly abundant proteins (24) and intracellular proteins (25) . Our results show important levels of globin and intracellular proteins only just after probe implantation. These levels subsequently decreased dramatically (p < 0.01) within one hour (data not shown).
Results

Microdialysis
Moreover, the lack of catalase and carbonic anhydrase in our microdialysate samples suggests that blood contamination is less than 0.005%, consistent with previous findings (24).
Striatum microdialysate proteome. The whole protein dataset, i.e. proteins whose expression was evidenced from tryptic fragments and endogenous peptides, is shown in Supplemental had been reported to be "secreted", 24 were reported to be located in the "cytoplasm", nine in the "membrane", and, surprisingly, one was reported to be present in the analyses performed with the 20-kDa probe. In the peptidomic data, extracellular matrix fibrinogen alpha and gamma were also evidenced as abundant protein precursors. In addition, spectrum counting was calculated for each classification including "molecular function", "cellular localization" and "secretory pathway". Fig. 3 shows relative quantification for different aCSF collection and analytical conditions. The precursors described as "secreted" accounted for 90%, 62% and 34% of the 100-kDa proteome, the 20-kDa-proteome and the 20-kDa peptidome, respectively ( Fig. 3.A) . The abundance of neurogranin, classified as cytoplasmic, accounts for the difference in "cellular localization" profile between 20-kDa and 100-kDa samples. SignalP and SecretomeP predictions showed that, whereas most of the proteins of the 100-kDa proteome were secreted by the "classical secretory pathway" (94%), the two secretion modes were equally used (53 and 47%) by the proteins of the 20-kDa proteome. In the 100-kDa proteome, the most abundant molecular functions were "transfer/carrier proteins" (39%)
and "protease inhibitor activity" (35%), whereas, in the 20-kDa proteome, the most abundant molecular functions were "neuropeptide hormone activity" (36%) and "calcium binding protein" (20%). The "neuropeptide hormone acitivity" function was also the most frequently recorded one in the peptidome (50%), followed by "extracellular matrix" (20%) (Fig. 3.B) .
Influence of depolarization on protein and peptide abundance. We induced neuronal depolarization using microdialysis probes with a 20-kDa cut-off point perfused with 145 mM KCl. To allow comparisons between samples, spectrum counting was normalized by number of assigned spectra (20, 21) . No significant differences were observed for proteomic data, even for neuropeptide precursors. This may be due to the trypic peptides generated from these very short neuropeptides not being resolved by MS because of their low MW. We therefore focused our analysis on peptidomic data. The total number of spectra assigned through peptidomic analysis differed significantly between basal (aCSF) and KCl conditions (31 ± 11 versus 53 ± 3.6, p < 0.05; n=6
replicates from 3 biological samples). This difference mainly rests on an increase for proteins (peptides) of the classical secretory pathway (23 ± 8.5 versus 40 ± 1.5, p< 0.05; n=6).
Spectrum counting showed a higher proportion of "neuropeptide hormone activity" in the KCl than in the aCSF perfusion condition (68.9 versus 49.7% of total spectrum counting)
, as indicated in Fig. 4 . Indeed, neuronal depolarization led to the detection of a series of proteins (CCKN, proSAAS, SCG1 and SCG2) corresponding to neuropeptide precursors absent in basal conditions. In addition, PENK and VGF, albeit present in the basal condition, displayed robust increase in the presence of KCl (Fig.5) .
Identification of new PENK neuropeptides.
In KCl-infused animals, our peptidome dataset revealed the presence of 16 non-opioid peptides originating from PENK (Supplemental Table 2 ), accounting for 18.9% of precursor sequence coverage. Based on this dataset, we were able to evidence three subsets of PENK peptides (Supplemental Fig. 1 ). The first subset corresponded to the sequence SPQLEDEAKE (PENK 198-207), which was previously shown to be a striatal processed and secreted peptide (15) . Given the general rules governing prohormones processing (cleavage at dibasic sites or before single Arg residues) (27-29), we hypothesized that peptides clustered in the two other subsets corresponded to truncated forms of the non-opioid Moreover, to deeply explore our dataset and obtain relative quantification of dialysate proteins, we performed spectrum counting analysis of samples collected using 100-and 20-kDa cut-off probes. For high-molecular weight samples, 90% of the protein population is described as "secreted". The classical secretion pathway, which successively transports proteins from endoplasmic reticulum to the Golgi apparatus, and finally into secretory vesicles, appears to be the major route (94%). For 20-kDa samples, 62% of the proteins were classified as "secreted", with a similar proportion being routed by the classical and non classical secretory pathway. For such samples, the relatively large fraction of proteins referred to as "cytoplasmic" may reflect alternative secretion mechanisms. Indeed, metabolic enzymes, cytoskeletal proteins and chaperones (33) have been shown to be secreted by the endocytic pathway (34, 35) . Repertoire of striatal neuropeptides. As expected, in the peptidome dataset, the most abundant endogenous peptides belong to the "neuropeptide hormone activity" category.
Neuropeptides are required for cell-to-cell communication in neurotransmission and for the regulation of endocrine functions. They are processed from protein precursors by a proteolytic mechanism, packaged into large dense-core vesicles, and released to bind receptors on the postsynaptic target neuron. Our peptidome dataset shows that these peptides were are all processed at dibasic sites or before single Arg residues, as previously reported for polypeptides detected in CSF (43) . In our peptidome, we evidenced new processed and secreted neuropeptides: 24-63 VGF peptide; 304-321 SCGI peptide; 114-133, 143-185 and 239-260 PENK peptides. Moreover, the processing of the 375-420 VGF peptide is suggested both by peptidomic (cleavage at dibasic 373-374 site) and proteomic data (cleavage at dibasic 421-422 site). Thus, our data add new candidates to prior studies of the rat neuropeptidome (44) (45) (46) .
We also detected a prohormone-like processed peptide (GPGPGGPGGAGGARGGAGGGPSGD), referred to as NEUG 55-78. To our knowledge, NEUG processing has never been reported. This protein has been described as "cytoplasmic" and its secretion is not predicted by bioinformatic tools.
While the presence of "cytoplasmic" peptides could result from normal degradation by exosomes, peptidomic data suggest a different process for NEUG peptides. NEUG displays an IQ motif involved in calmodulin binding. However, the processed peptide present in microdialysates does not contain this motif. Furthermore, the protein displays several dibasic sites, a feature present in neuropeptide precursors, and the C-terminal 55-78 NEUG peptide is specifically processed at one such dibasic site (53-54). This prohormone-like processing and the high abundance of NEUG peptides in microdialysates are highly consistent with striatal secretion and suggest a new bioactivity for NEUG. The absence of a signal peptide in NEUG suggests that this peptide is secreted via a non classical secretory mechanism.
Identification of new biologically active neuropeptides. As expected, the three nonopioid PENK peptides (PENK 114-133, PENK 143-185, and PENK 239-260) described here are encompassed by dibasic sites, consistent with their production via a prohormone convertase activity. One characteristic feature of these peptides is a very high content of acidic residues, a hallmark for secreted peptides (43, 47, 48 decreases the release of GABA. As the endopeptidase process ensures the release of all PENK peptides into the extracellular space, it is worth emphasizing that opioid and non opioid peptides originating from PENK exert opposite effects on neurotransmitters.
In conclusion, the versatile proteomic approach described here enables in-depth characterization of the rat striatal secretome. Furthermore, we demonstrate that a combination of microdialysis sampling and peptidomic analysis can be used to identify new biologically active neuropeptides, and to explore temporally and spatially their release process in specific brain regions. 
